my account  log out
 

Anti-TNFRSF8 (Brentuximab-LC-N152)-DBCO-MMAF ADC

Create: 04/27/2019
Expired Date:never
Category: Drugs&Pharmaceutical [Health&Medical&Pharmaceutical]
Message:This ADC product is comprised of an anti-TNFRSF8 monoclonal antibody (Brentuximab variant,LC-N152) conjugated via a DBCO linker to MMAF. The MMAF is targeted to certain cancers by immunerecognition and delivered into cancer cells via receptor mediated endocytosis. Within the cell, MMAF binds to tubulins, interrupts microtubule dynamics, and subsequently, induces cell death.https://www.creative-biolabs.com/adc/target-tnfrsf8-99.htm
City:Shirley[US] 
Location:
 
Feb 01 2023 VBS++ (with Ca and Mg) Buffer214
Feb 01 2023 GVBE Buffer214
Feb 01 2023 GVB++ (with Ca and Mg) Buffer221
Feb 01 2023 Hemolysin (Rabbit Anti-Sheep Cell Hemolysin)208
Aug 30 2019Anti-HSV-2 gH Antibody393
Aug 30 2019Anti-L. major LPG Antibody476
Aug 30 2019Anti-DENV-1 Antibody385
Aug 30 2019Anti-BPV-1 L1 Antibody401
Aug 30 2019Anti-H3N2 HA Antibody387
Aug 30 2019Anti-EIAV env Antibody411

return back

Copyright © toextrade Inc. All rights reserved. Contact us